Shares in Bruker BioSciences and Stratagene continued their bumpy ride, bouncing back this week to post gains of 8.42 percent and 6.74 percent, respectively. Both firms' stocks had led decliners in the BCW Index last week, following a week of big gains.

Molecular Devices posted the largest decline for the week — 2.96 percent — giving back its gain of 2.69 percent during last week's tracking period.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.